MON-315 Transcription Factor NRF2 May Serve as a Master Regulator of Immune Modulation and Lung Cancer Progression

Lung cancer contributes to the highest rates of cancer-related deaths world-wide. Approximately 80% of lung cancers are non-small cell lung cancers (NSCLC), and adenocarcino­mas (adenoCa) comprise about half of these. Importantly, >20% of lung adenoCa harbor mutations in transcription factor NRF2...

Descripción completa

Detalles Bibliográficos
Autor principal: Mishra, Ritu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Tumor Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550722/
http://dx.doi.org/10.1210/js.2019-MON-315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550722/
http://dx.doi.org/10.1210/js.2019-MON-315

Ejemplares similares